Cambridge Investment Research Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 5,437 shares of JAZZ stock, worth $739,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,437
Previous 6,215
12.52%
Holding current value
$739,486
Previous $692,000
3.18%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$836 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$821 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$344 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$301 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$277 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.53B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...